Abstract:Prostate cancer (PC), which responds well to androgen ablation initially, invariably progresses to treatment resistance. The so-called androgen-independent PC is also a concern, since there is no effective therapy so far. Nkx3.1 is a putative prostate tumor suppressor that is expressed exclusively in the prostate under the regulation of androgen, and p27(KIP1) functions as a cell proliferation inhibitor and apoptosis trigger by disrupting the cyclin-dependent kinase (CDK)-cyclin complex. Lack of expressions of Nkx3.1 and/or p27(KIP1) have been detected in most advanced PC and is associated with poor clinical progression. Here, we show that endogenous expressions of both Nkx3.1 and p27(KIP1) are lost in the androgen-independent PC3 PC cells, while remaining intact in LNCaP PC cells, which contain functional androgen receptor (AR) and are hormone-responsive. Ectopic restoration of either Nkx3.1 or p27(KIP1) in PC3 cells results in reduced cell proliferation, and increased cell death. Both effects are synergistically enhanced when the two molecules are coexpressed. p27(KIP1) overexpression in PC3 results in increased cell population ceased at the G0/G1 phase, and this cell-cycle-arresting effect is significantly enhanced by the coexpression of Nkx3.1. Flow cytometry further revealed that Nkx3.1 and p27(KIP1) also cooperatively render more PC3 cells undergoing apoptosis. Consistently, the coexpression of Nkx3.1 and p27(KIP1) leads to the decreased expression of Bcl-2 oncogene and a concomitantly upregulated Bax expression. It also activates caspase 3 and leads to increased cleavage of PARP. Our findings thus reveal the crucial relevance of the combined antiproliferative and proapoptotic activities of Nkx3.1 and p27(KIP1) in androgen-independent PC cells, and further suggest that a combined, rather than single gene manipulation may be of clinical value for hormone-refractory PC.

Expression of P27kip1 and CDKs in Prostate Carcinoma and Benign Prostate Hyperplasia Tissues

Nkx3.1 and P27kip1cooperate in Proliferation Inhibition and Apoptosis Induction in Human Androgen–Independent Prostate Cancer Cells

[Expression of Tyrosine Phosphatase Containing C-src Homology SH-2 in Benign Prostate Hyperplasia].

[Expression and Clinical Significance of Ser10 Phosphorylated P27(kip1) Protein in Human Breast Carcinoma].

Synergistic effect of Nkx3.1 and p27 Proteins in Human prostate cancer cells

[Expression and Significance of PCNA and P27 in Benign Prostate Hypertrophy and Prostate Carcinoma].

[Expression of Cyclin D1 and P27kip1 in Renal Cell Carcinoma and Its Significance].

Expression of P27kip1 in Prostatic Intraepithelial Neoplasia Cel Ls

[Correlation of Skp2 and P27kip1 Protein Expression and Clinicopathological Features of Prostate Cancer].

The Expression and Significance of P27kip1, Skp2 in Breast Cancer

Correlations Between Skp2 and P27~(kip1) Protein Expressions and Clinicopathological Features of Prostate Cancer

Expression of P27(kip1), Rb Protein and Proliferating Cell Nuclear Antigen and Its Relationship with Clinicopathology in Human Pancreatic Cancer.

Expression and Clinical Significance of Novel Protein Kinase C Ε in Prostate Cancer Tissuss

Prognostic implication of p27 Kip1 , Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study

Expression and Significance of P504s and PCNA in Human Prostatic Carcinoma

Expression of Kallikrein-Related Peptidase 7 is Decreased in Prostate Cancer

Expression of Skp2 and P27~(kip1)in Colorectal Carcinoma and Their Clinical Significance

Correlations Between Skp2, P27kipl,pten Protein Expression and the Clinicopathological Features of Prostate Cancer

Expression of P27kip1 in resectable pancreatic carcinoma and its clinical significance

P27kip1 and Ser10-phosphorylated P27kip1 in Breast Cancer: Clinical Significance and Expression

Clinical significance of p27Kip1 expression in breast cancer at clinical stage Ⅰ and Ⅱ